Ryan M. Carr

1.2k total citations
34 papers, 436 citations indexed

About

Ryan M. Carr is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ryan M. Carr has authored 34 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Ryan M. Carr's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Myeloid Leukemia Research (7 papers). Ryan M. Carr is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Myeloid Leukemia Research (7 papers). Ryan M. Carr collaborates with scholars based in United States, Italy and Canada. Ryan M. Carr's co-authors include Martín E. Fernández-Zapico, Bellur S. Prabhakar, Mrinal M. Patnaik, Terra L. Lasho, Abhishek A. Mangaonkar, Christy M. Finke, Moritz Binder, Sharon Walton, Naseema Gangat and William M. Mihalko and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ryan M. Carr

30 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan M. Carr United States 12 202 132 101 96 71 34 436
Chunji Gao China 10 202 1.0× 133 1.0× 125 1.2× 83 0.9× 72 1.0× 38 382
Takuma Ishizaki Japan 11 193 1.0× 113 0.9× 54 0.5× 61 0.6× 88 1.2× 45 414
Ganesan Keerthivasan United States 9 283 1.4× 80 0.6× 65 0.6× 76 0.8× 89 1.3× 13 489
Merete Thune Wiiger Norway 11 201 1.0× 233 1.8× 86 0.9× 56 0.6× 80 1.1× 20 515
Sandra Gottschling Germany 11 154 0.8× 74 0.6× 68 0.7× 189 2.0× 91 1.3× 16 431
Zhifu Xiang United States 7 176 0.9× 160 1.2× 78 0.8× 76 0.8× 79 1.1× 22 355
Stefan O. Peters Germany 8 162 0.8× 186 1.4× 101 1.0× 114 1.2× 66 0.9× 15 390
Naoto Nakamichi Japan 12 173 0.9× 94 0.7× 48 0.5× 97 1.0× 89 1.3× 22 366
Shirin Azizidoost Iran 12 256 1.3× 120 0.9× 83 0.8× 80 0.8× 67 0.9× 44 465
Christian Binet France 12 110 0.5× 191 1.4× 75 0.7× 94 1.0× 105 1.5× 22 355

Countries citing papers authored by Ryan M. Carr

Since Specialization
Citations

This map shows the geographic impact of Ryan M. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan M. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan M. Carr more than expected).

Fields of papers citing papers by Ryan M. Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan M. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan M. Carr. The network helps show where Ryan M. Carr may publish in the future.

Co-authorship network of co-authors of Ryan M. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan M. Carr. A scholar is included among the top collaborators of Ryan M. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan M. Carr. Ryan M. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherry, Alexander D., et al.. (2025). Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. Seminars in Radiation Oncology. 35(4). 495–509.
2.
Hálfdánarson, Þorvarður R., Erin E. Carlson, Kari G. Rabe, et al.. (2025). Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma. Endocrine Related Cancer. 32(4). 1 indexed citations
3.
Leiting, Jennifer L., Jennifer A. Yonkus, Amro M. Abdelrahman, et al.. (2025). Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study. Annals of Surgical Oncology. 32(6). 4453–4463.
4.
Desai, Aakash, Daheui Choi, Þorvarður R. Hálfdánarson, et al.. (2024). Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers. 16(10). 1861–1861. 1 indexed citations
5.
Gatenby, Robert A., Kimberly A. Luddy, Jamie K. Teer, et al.. (2024). Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways. Medical Oncology. 41(6). 135–135.
6.
McWilliams, Robert R., Pashtoon Murtaza Kasi, Nathan R. Foster, et al.. (2023). Trial in progress: Phase II study of niraparib and dostarlimab for the treatment of germline or somatic homologous recombination repair mutated metastatic pancreatic cancer.. Journal of Clinical Oncology. 41(4_suppl). TPS780–TPS780. 3 indexed citations
7.
Gleeson, Ferga C., Lisa A. Kottschade, Katie A. Dunleavy, et al.. (2023). Tu1420 INCIDENCE AND EFFECT DURATION OF IMMUNE CHECKPOINT INHIBITOR RELATED PANCREAS ADVERSE EVENTS. Gastroenterology. 164(6). S–1049. 1 indexed citations
8.
Gatenby, Robert A., et al.. (2022). Ecoevolutionary biology of pancreatic ductal adenocarcinoma. Pancreatology. 22(6). 730–740. 5 indexed citations
9.
Binder, Moritz, Ryan M. Carr, Terra L. Lasho, et al.. (2022). Oncogenic gene expression and epigenetic remodeling of cis-regulatory elements in ASXL1-mutant chronic myelomonocytic leukemia. Nature Communications. 13(1). 1434–1434. 14 indexed citations
10.
Carr, Ryan M., Zhaohui Jin, & Joleen M. Hubbard. (2021). Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer. Cancers. 13(9). 2180–2180. 5 indexed citations
11.
Bezerra, Evandro D., Giacomo Coltro, Terra L. Lasho, et al.. (2020). Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients. Leukemia. 35(2). 644–649. 7 indexed citations
12.
Carr, Ryan M., Narjust Duma, Angela L. McCleary‐Wheeler, et al.. (2020). Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 20(6). 1115–1122. 17 indexed citations
13.
Montagnani, Valentina, et al.. (2020). E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis. Journal of Biological Chemistry. 295(47). 16058–16071. 11 indexed citations
14.
Carr, Ryan M., Paola Romecín, Ezequiel J. Tolosa, et al.. (2020). The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex. Journal of Biological Chemistry. 295(9). 2698–2712. 12 indexed citations
15.
Vallapureddy, Rangit, Terra L. Lasho, Christy M. Finke, et al.. (2019). Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients. American Journal of Hematology. 94(7). 767–779. 49 indexed citations
16.
Coltro, Giacomo, Abhishek A. Mangaonkar, Terra L. Lasho, et al.. (2019). Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients. Leukemia. 34(5). 1407–1421. 63 indexed citations
17.
Carr, Ryan M. & Martín E. Fernández-Zapico. (2016). Pancreatic cancer microenvironment, to target or not to target?. EMBO Molecular Medicine. 8(2). 80–82. 42 indexed citations
18.
Maker, Ajay V. & Ryan M. Carr. (2015). Techniques to perform a laparoscopic right adrenalectomy for metastases abutting the liver, renal vein, and posterior vena cava. Surgical Endoscopy. 30(3). 1226–1226. 2 indexed citations
19.
Carr, Ryan M., Yousef Shishani, & Reuben Gobezie. (2015). How Accurate Are We in Detecting Biceps Tendinopathy?. Clinics in Sports Medicine. 35(1). 47–55. 9 indexed citations
20.
Galvani, D. W., et al.. (1992). Endolymphatic delivery of IL2 in patients with melanoma and lymphoma. Biotherapy. 4(4). 251–255. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunji Gao Breakdown of academic impact, for papers by Takuma Ishizaki Breakdown of academic impact, for papers by Ganesan Keerthivasan Breakdown of academic impact, for papers by Merete Thune Wiiger Breakdown of academic impact, for papers by Sandra Gottschling Breakdown of academic impact, for papers by Zhifu Xiang Breakdown of academic impact, for papers by Stefan O. Peters Breakdown of academic impact, for papers by Naoto Nakamichi Breakdown of academic impact, for papers by Shirin Azizidoost Breakdown of academic impact, for papers by Christian Binet
Rankless by CCL
2026